Ignite Creation Date:
2024-05-06 @ 1:31 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04049799
Status:
COMPLETED
Last Update Posted:
2024-02-08
First Post:
2019-07-23
Brief Title:
Maternal Opioid Treatment Human Experimental Research - Data Yield Appropriate Decisions
Sponsor:
University of Vermont
Organization:
University of Vermont
Study Overview
Official Title:
Medically-supervised Withdrawal vs Agonist Maintenance in the Treatment of Pregnant Women With Opioid Use Disorder Maternal Fetal and Neonatal Outcomes
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MOTHER DYAD
Brief Summary:
This study will compare medically-supervised withdrawal MSW detoxification to opioid agonist treatment OAT maintenance with buprenorphine for pregnant women with opioid use disorder in terms of maternal fetal and neonatal outcomes Outcomes will be assessed during pregnancy at birth and for 12 months postpartum This study has the potential to impact health service policy and practices in terms of the treatment options of pregnant women with opioid use disorder
Detailed Description:
Some inclusionexclusion criteria are purposely omitted at this time to preserve scientific integrity They will be included after the trial is complete
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DA047867 | NIH | None | httpsreporternihgovquickSearchR01DA047867 |